ArticleAmerican journal of cancer research2024

PDK3 drives colorectal carcinogenesis and immune evasion and is a therapeutic target for boosting immunotherapy.

Zhiqiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.